Average Co-Inventor Count = 5.39
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi-a Ventis Deutschland Gmbh (10 from 1,827 patents)
2. Sanofi (10 from 1,451 patents)
3. Sanofi-aventis (3 from 389 patents)
23 patents:
1. 9718825 - N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals
2. 9346762 - Pyrazole derivatives and their use as LPAR5 antagonists
3. 9346757 - Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
4. 9221784 - Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists
5. 9221828 - N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals
6. 9174993 - N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
7. 8669266 - Quinoline-carboxamide derivatives as P2Y12 antagonists
8. 8487109 - Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
9. 8420812 - Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
10. 8283476 - Transition metal catalyzed synthesis of 2H-indazoles
11. 8188282 - Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
12. 8088925 - Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors
13. 8026375 - Transition metal catalyzed synthesis of N-aminoindoles
14. 7910606 - Pyrazole-derivatives as factor Xa inhibitors
15. 7741341 - Benzimidazole-derivatives as factor Xa inhibitors